Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation

British Journal of Haematology

Volumn 129, Issue 5, 2005, Pages 687-700

  Vasir, Baldev ^a,c   Borges, Virginia ^b   Wu, Zekui ^a   Grosman, Daren ^b   Rosenblatt, Jacalyn ^b   Irie, Masaki ^a   Anderson, Kenneth ^a   Kufe, Donald ^a   Avigan, David ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Chemokines; Co stimulation; Dendritic cells; Tumour immunity; Vaccination

Indexed keywords

CANCER VACCINE; CD34 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 12; MACROGOL;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL FUSION; CELL MATURATION; CELL MIGRATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MULTIPLE MYELOMA; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIGEN PRESENTATION; ANTIGENS, CD34; CANCER VACCINES; CELL FUSION; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; HYBRID CELLS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MULTIPLE MYELOMA; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 20444495703     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05507.x     Document Type: Article

References (75)

1. Albert, M.L., Sauter, B. & Bhardwaj, N. (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature, 392, 86-89.
2. Ashley, D.M., Faiola, B., Nair, S., Hale, L.P., Bigner, D.D. & Gilboa, E. (1997) Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. The Journal of Experimental Medicine, 186, 1177-1182.
3. Askew, D., Chu, R.S., Krieg, A.M. & Harding, C.V. (2000) CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. Journal of Immunology (Baltimore, MD: 1950), 165, 6889-6895.
4. Austyn, J.M. (1996) New insights into the mobilization and phagocytic activity of dendritic cells. The Journal of Experimental Medicine, 183, 1287-1292.
5. Avigan, D. (1999) Dendritic cells: development, function and potential use for cancer immunotherapy. Blood Reviews, 13, 51-64.
6. Avigan, D., Vasir, B., Gong, J., Borges, V., Wu, Z., Uhl, L., Atkins, M., Mier, J., McDermott, D., Smith, T., Giallambardo, N., Stone, C., Schadt, K., Dolgoff, J., Tetreault, J.C., Villarroel, M. & Kufe, D. (2004) Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses. Clinical Cancer Research An Official Journal of the American Association for Cancer Research, 10, 4699-4708.
7. Banchereau, J. & Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature, 392, 245-252.
8. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B. & Palucka, K. (2000) Immunobiology of dendritic cells. Annual Review of Immunology, 18, 767-811.
9. Basu, S., Binder, R.J., Suto, R., Anderson, K.M. & Srivastava, P.K (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. International Immunology, 12, 1539-1546.
10. Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G.M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K.A. & Banchereau, J. (1999) In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. The Journal of Experimental Medicine, 190, 1417-1426.
11. + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Research, 55, 1099-1104.
12. + CTL responses in vitro. The Journal of Clinical Investigation, 98, 715-722.
13. Brown, R.D., Pope, B., Murray, A., Esdale, W., Sze, D.M., Gibson, J., Joy Ho, P., Hart, D. & Joshua, D. (2001) Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-b1 and interleukin-10. Blood, 98, 2992-2998.
14. Brunner, C., Seiderer, J., Schlamp, A., Bidlingmaier, M., Eigler, A., Haimerl, W., Lehr, H.A., Krieg, A.M., Hartmann, G. & Endres, S. (2000) Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti- tumor immune responses in vivo. Journal of Immunology (Baltimore, MD: 1950), 165, 6278-6286.
15. Cao, X., Zhang, W., Wang, J., Zhang, M., Huang, X., Hamada, H. & Chen, W. (1999) Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colonystimulating factor genetically modified dendritic cells. Immunology, 97, 616-625.
16. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. & Alber, G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. The Journal of Experimental Medicine, 184, 747-752.
17. Celluzzi, C.M. & Falo, L.D., (1998) Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. Journal of Immunology (Baltimore, MD: 1950), 160, 3081-3085.
18. Chen, Z., Moyana, T., Saxena, A., Warrington, R., Jia, Z. & Xiang, J. (2001) Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. International Journal of Cancer, 93, 539-548.
19. Corinti, S., Albanesi, C., la Sala, A., Pastore, S. & Girolomoni, G. (2001) Regulatory activity of autocrine IL-10 on dendritic cell functions. Journal of Immunology, 166, 4312-4318.
20. D'Amico, G., Frascaroli, G., Bianchi, G., Transidico, P., Doni, A., Vecchi, A., Sozzani, S., Allavena, P. & Mantovani, A. (2000) Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nature Immunology, 1, 387-391.
21. De Smedt, T., Van Mechelen, M., De Becker, G., Urbain, J., Leo, O. & Moser, M. (1997) Effect of interleukin-10 on dendritic cell maturation and function. European Journal of Immunology, 27, 1229-1235.
22. De Vries, I.J., Krooshoop, D.J., Scharenborg, N.M., Lesterhuis, W.J., Diepstra, J.H., Van, Muijen, G.N., Strijk, S.P., Ruers, T.J., Boerman, O.C., Oyen, W.J., Adema, G.J., Punt, C.J. & Figdor, C.G. (2003) Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Research, 63, 12-17.
23. Dieu, M.C, Vanbervliet, B., Vicari, A., Bridon, J.M., Oldham, E., Ait-Yahia, S., Briere, F., Zlotnik, A., Lebecque, S. & Caux, C (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. The Journal of Experimental Medicine, 188, 373-386.
24. Do, T.H., Johnson, H.E., Kjaersgaard, E., Taaning, E. & Svane, I.M. (2004) Impaired circulating myeloid DCs from myeloma patients. Cytotherapy, 6, 196-203.
25. Goldmann, O., Rohde, M. & Medina, E. (2002) Phagocytosis of bacille Calmette-Guâerin-infected necrotic macrophages induces a maturation phenotype and evokes antigen-presentation functions in dendritic cells. Immunology, 107, 500-506.
26. Gong, J., Chen, D., Kashiwaba, M. & Kufe, D. (1997) Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nature Medicine, 3, 558-561.
27. Gong, J., Avigan, D., Chen, D., Wu, Z., Koido, S., Kashiwaba, M. & Kufe, D. (2000a) Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America, 97, 2715-2718.
28. Gong, J., Nikrui, N., Chen, D., Koido, S., Wu, Z., Tanaka, Y., Cannistra, S., Avigan, D. & Kufe, D. (2000b) Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. Journal of Immunology (Baltimore, MD: 1950), 165, 1705-1711.
29. Ignatius, R., Marovich, M., Mehlhop, E., Villamide, L., Mahnke, K., Cox, W.I., Isdell, F., Frankel, S.S., Mascola, J.R., Steinman, R.M. & Pope, M. (2000) Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion. Journal of Virology, 74, 11329-11338.
30. Ip, W.K. & Lau, Y.L. (2004) Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. Journal of Immunology (Baltimore, MD: 1950), 173, 189-196.
31. Jeannin, P., Renno, T., Goetsch, L., Miconnet, I., Aubry, J.P., Delneste, Y., Herbault, N., Haussant, T., Magistrelli, G., Soulas, C., Romero, P., Cerottini, J.C. & Bonnefoy, J.Y. (2000) OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nature Immunology, 1, 502-509.
32. Kelleher, P. & Knight, S.C. (1998) IL-12 increases CD80 expression and the stimulatory capacity of bone marrow-derived dendritic cells. International Immunology, 10, 749-755.
33. Kelsall, B.L., Stuber, E., Neurath, M. & Strober, W. (1996) Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Annals of the New York Academy of Sciences, 795, 116-126.
34. Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kampgen, E., Romani, N. & Schuler, G. (1996) High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. The Journal of Experimental Medicine, 184, 741-746.
35. Lanzavecchia, A. (1999) Dendritic cell maturation and generation of immune responses. Haematologica, 84(Suppl. EHA-4), 23-25.
36. Lee, J.J., Takei, M., Hori, S., Inoue, Y., Harada, Y., Tanosaki, R., Kanda, Y., Kami, M., Makimoto, A., Mineishi, S., Kawai, H., Shimosaka, A., Heike, Y., Ikarashi, Y., Wakasugi, H., Takaue, Y., Hwang, T.J., Kim, H.J. & Kakizoe, T. (2002) The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression? Stem Cells, 20, 448-459.
37. Lespagnard, L., Mettens, P., Verheyden, A.M., Tasiaux, N., Thielemans, K., van Meirvenne, S., Geldhof, A., De Baetselier, P., Urbain, J., Leo, O. & Moser, M. (1998) Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity. International journal of cancer. Journal International du Cancer, 76, 250-258.
38. Liu, Y., Zhang, W., Chan, T., Saxena, A. & Xiang, J. (2002) Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity. Leukemia Research, 26, 757-763.
39. + T cells. Journal of Immunology (Baltimore, MD: 1950), 154, 5071-5079.
40. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D., Melief, C.J., Ildstad, S.T., Kast, W.M., Deleo, A.B. & Lotze, M.T. (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Medicine, 1, 1297-1302.
41. Menetrier-Caux, C., Montmain, G., Dieu, M.C., Bain, C., Favrot, M.C., Caux, C. & Blay, J.Y. (1998) Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood, 92, 4778-4791.
42. Mosca, P.J., Hobeika, A.C., Clay, T.M., Nair, S.K., Thomas, E.K., Morse, M.A. & Lyerly, H.K. (2000) A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment. Blood, 96, 3499-3504.
43. Nair, S.K., Boczkowski, D., Morse, M., Cumming, R.I., Lyerly, H.K. & Gilboa, E. (1998) Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotechnology, 16, 364-369.
44. Paglia, P., Chiodoni, C., Rodolfo, M. & Colombo, M.P. (1996) Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. The Journal of Experimental Medicine, 183, 317-322.
45. Parkhurst, M.R., DePan, C., Riley, J.P., Rosenberg, S.A. & Shu, S. (2003) Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules. Journal of Immunology (Baltimore, MD: 1950), 170, 5317-5325.
46. Parlato, S., Santini, S.M., Lapenta, C., Di Pucchio, T., Logozzi, M., Spada, M., Giammarioli, A.M., Malorni, W., Fais, S. & Belardelli, F. (2001) Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type 1 IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood, 98, 3022-3029.
47. Pfeiffer, S., Gooding, R.P., Apperley, J.F., Goldschmidt, H. & Samson, D. (1997) Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors. British Journal of Haematology, 98, 973-982.
48. Qin, Z., Noffz, G., Mohaupt, M. & Blankenstein, T. (1997) Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. Journal of Immunology (Baltimore, MD: 1950), 159, 770-776.
49. Rad, A.N., Pollara, G., Sohaib, S.M., Chiang, C., Chain, B.M. & Katz, D.R. (2003) The differential influence of allogeneic tumor cell death via DNA damage on dendritic cell maturation and antigen presentation. Cancer Research, 63, 5143-5150.
50. + T cells. International Journal of Cancer, 105, 811-819.
51. Raje, N., Gong, J., Chauhan, D., Teoh, G., Avigan, D., Wu, Z., Chen, D., Treon, S.P., Webb, I.J., Kufe, D.W. & Anderson, K.C. (1999) Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences. Blood, 93, 1487-1495.
52. Ratta, M., Fagnoni, F., Curti, A., Vescovini, R., Sansoni, P., Oliviero, B., Fogli, M., Ferri, E., Robustelli, G., Cuna, D., Tura, S., Baccarani, M. & Lemoli, R.M. (2002) Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood, 100, 230-237.
53. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P.O., Steinman, R.M. & Schuler, G. (1994) Proliferating dendritic cell progenitors in human blood. The Journal of Experimental Medicine, 180, 83-93.
54. Rouard, H., Marquet, J., Leon, A., Maison, P., Haioun, C., Copie-Bergman, C., Plonquet, A., Farcet, J.P. & Delfau-Larue, M.H. (2002) 1L-12 secreting dendritic cells are required for optimum activation of human secondary lymphoid tissue T cells. Journal of Immunotherapy, 25, 324-333.
55. Sallusto, F. & Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. The Journal of Experimental Medicine, 179, 1109-1118.
56. Sallusto, F. & Lanzavecchia, A. (2000) Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunological Reviews, 177, 134-140.
57. Sallusto, F., Palermo, B., Lenig, D., Miettinen, M., Matikainen, S., Julkunen, I., Forster, R., Burgstahler, R., Lipp, M. & Lanzavecchia, A. (1999) Distinct patterns and kinetics of chemokine production regulate dendritic cell function. European Journal of Immunology, 29, 1617-1625.
58. Sauter, B., Albert, M.L., Francisco, L., Larsson, M., Somersan, S. & Bhardwaj, N. (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. The Journal of Experimental Medicine, 191, 423-434.
59. Scandella, E., Men, Y., Gillessen, S., Forster, R. & Groettrup, M. (2002) Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood, 100, 1354-1361.
60. Sertl, K., Takemura, T., Tschachler, E., Ferrans, V.J., Kaliner, M.A. & Shevach, E.M. (1986) Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. The Journal of Experimental Medicine, 163, 436-451.
61. Sozzani, S., Allavena, P., D'Amico, G., Luini, W., Bianchi, G., Kataura, M., Imai, T., Yoshie, O., Bonecchi, R. & Mantovani, A. (1998) Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. Journal of Immunology, 161, 1083-1086.
62. Sozzani, S., Allavena, P., Vecchi, A. & Mantovani, A. (2000) Chemokines and dendritic cell traffic. Journal of Clinical Immunology, 20, 151-160.
63. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. & Enk, A.H. (1997) Induction of tolerance by IL-10-treated dendritic cells. Journal of Immunology (Baltimore, MD: 1950), 159, 4772-4780.
64. Steinbrink, K., Graulich, E., Kubsch, S., Knop, J. & Enk, A.H. (2002) CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood, 99, 2468-2476.
65. Steinman, R.M. (1991) The dendritic cell system and its role in immunogenicity. Annual Review of Immunology, 9, 271-296.
66. Steinman, R.M. & Swanson, J. (1995) The endocytic activity of dendritic cells. The Journal of Experimental Medicine, 182, 283-288.
67. Stuart, L.M., Lucas, M., Simpson, C., Lamb, J., Savill, J. & Lacy-Hulbert, A. (2002) Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. Journal of Immunology (Baltimore, MD: 1950), 168, 1627-1635.
68. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. Journal of Immunology (Baltimore, MD: 1950), 154, 5851-5861.
69. Szabolcs, P., Avigan, D., Gezelter, S., Ciocon, D.H., Moore, M.A., Steinman, R.M. & Young, J.W. (1996) Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood, 87, 4520-4530.
70. Takayama, T., Nishioka, Y., Lu, L., Lotze, M.T., Tahara, H. & Thomson, A.W. (1998) Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation, 66, 1567-1574.
71. Takayama, T., Morelli, A.E., Onai, N., Hirao, M., Matsushima, K., Tahara, H. & Thomson, A.W. (2001) Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down- regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability. Journal of Immunology, 166, 7136-7143.
72. + progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CDla(+)CD86(+)Langerin+ phenotypes. International Journal of Cancer, 110, 710-720.
73. Young, J.W. & Steinman, R.M. (1996) The hematopoietic development of dendritic cells: a distinct pathway for myeloid differentiation. Stem Cells, 14, 376-387.
74. Zhou, L.J. & Tedder, T.F. (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. Journal of Immunology (Baltimore, MD: 1950), 154, 3821-3835.
75. Zitvogel, L., Couderc, B., Mayordomo, J.I., Robbins, P.D., Lotze, M.T. & Storkus, W.J. (1996) IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Annals of the New York Academy of Sciences, 795, 284-293.